Valley Forge Investment Consultants Inc Adv »

Silverback Therapeutics shares owned by Valley Forge Investment Consultants Inc Adv

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Valley Forge Investment Consultants Inc Adv from 13F filings

Historical chart of Valley Forge Investment Consultants Inc Adv investment in Silverback Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 290.9M1M1.1M1.2M83.224k83.2245k83.225k83.2255k83.226k
Value ($)Share countHistorical SPRY position of Valley Forge Investment … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Valley Forge Investment Consultants Inc Adv consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Valley Forge Investment Consultants Inc Adv

Quarter filed Position value Share count Share price at filing
2024-12-31 $878k 83k 10.55
2024-09-30 $1.2M 83k 14.50

More positions owned by Valley Forge Investment Consultants Inc Adv

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Rus 1000 Grw Etf (IWF)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Dimensional Etf Trust Us Core Equity 2 (DFAC)

View all positions for Valley Forge Investment Consultants Inc Adv

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics